These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9737816)

  • 1. Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
    Park JH; Lee WI; Yoon WH; Park YD; Lee JS; Lee MG
    Biopharm Drug Dispos; 1998 Sep; 19(6):357-64. PubMed ID: 9737816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
    Park KJ; Yoon WH; Shin WG; Lee MG
    J Pharm Pharmacol; 1996 Oct; 48(10):1093-7. PubMed ID: 8953515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus.
    Kim SH; Kim WB; Lee MG
    Biopharm Drug Dispos; 1998 Jul; 19(5):303-8. PubMed ID: 9673782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of furosemide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
    Jang SH; Lee MG; Kim ND
    Biopharm Drug Dispos; 1994 Apr; 15(3):185-206. PubMed ID: 7880980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
    Lee WI; Yoon WH; Shin WG; Song IS; Lee MG
    Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Ha HA; Lee SH; Kim SH; Kim ON; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):109-28. PubMed ID: 8865375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition.
    Kim SH; Choi YM; Lee MG
    J Pharmacokinet Biopharm; 1993 Feb; 21(1):1-17. PubMed ID: 8410679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced absorption of oral furosemide by bile juice in rats.
    Kim EJ; Han KS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):107-10. PubMed ID: 10604283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
    Kim SH; Park KJ; Yoon WH; Lee JW; Kim ND; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study.
    Silbert BI; Ho KM; Lipman J; Roberts JA; Corcoran TB; Morgan DJ; Pavey W; Mas E; Barden AE; Mori TA
    Crit Care Med; 2016 Oct; 44(10):e923-9. PubMed ID: 27183025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats.
    Lee AK; Kim EJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():193-200. PubMed ID: 15686118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.
    Kim YC; Oh EY; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Nov; 26(8):371-8. PubMed ID: 16094676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition.
    Kim YG; Cho MK; Kwon JW; Kim SG; Kim SH; Lee MG
    Life Sci; 2001 Apr; 68(21):2329-45. PubMed ID: 11350005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.
    Choi YJ; Lee HJ; Kwon JW; Kim WB; Yang J; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Nov; 94(2):181-92. PubMed ID: 8987115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats.
    Kang MJ; Yoon WH; Kim ON; Lee MG
    J Clin Pharm Ther; 1995 Feb; 20(1):13-21. PubMed ID: 7775609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide.
    Bindschedler M; Degen P; Flesch G; de Gasparo M; Preiswerk G
    Eur J Clin Pharmacol; 1997; 52(5):371-8. PubMed ID: 9272406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.